3rd Quarter - Report
SIDLEY AUSTIN LLP for DUKE UNIVERSITY MEDICAL CENTER
Firm
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA LOUISE DELOATCHE | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis |
Medical/Disease Research/Clinical Labs MED
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA LOUISE DELOATCHE | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis |
Health Issues HCR
Federal funding for NCBI, passage of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA LOUISE DELOATCHE | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, and Legislative Assistant, Rep. Mike Bilirakis |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.